Albert ML - Search Results

1

Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.

Wolfe N, Katz DI, Albert ML, Almozlino A, Durso R, Smith MC, Volicer L. Wolfe N, et al. Among authors: albert ml. J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):915-7. doi: 10.1136/jnnp.53.10.915. J Neurol Neurosurg Psychiatry. 1990. PMID: 2266376 Free PMC article.

2

Speech monitoring skills in Alzheimer's disease, Parkinson's disease, and normal aging.

McNamara P, Obler LK, Au R, Durso R, Albert ML. McNamara P, et al. Among authors: albert ml. Brain Lang. 1992 Jan;42(1):38-51. doi: 10.1016/0093-934x(92)90055-j. Brain Lang. 1992. PMID: 1547468 Free article.

3

GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice.

Fazzini E, Durso R, Davoudi H, Szabo GK, Albert ML. Fazzini E, et al. Among authors: albert ml. J Neurol Sci. 1990 Oct;99(1):59-68. doi: 10.1016/0022-510x(90)90199-w. J Neurol Sci. 1990. PMID: 2250172 Free article.

4

Frontal systems impairment following multiple lacunar infarcts.

Wolfe N, Linn R, Babikian VL, Knoefel JE, Albert ML. Wolfe N, et al. Among authors: albert ml. Arch Neurol. 1990 Feb;47(2):129-32. doi: 10.1001/archneur.1990.00530020025010. Arch Neurol. 1990. PMID: 2302084

5

Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease.

Rainero I, Kaye JA, May C, Durso R, Katz DI, Albert ML, Wolfe N, Pinessi L, Friedland RP, Rapoport SI. Rainero I, et al. Among authors: albert ml. Arch Neurol. 1988 Nov;45(11):1224-7. doi: 10.1001/archneur.1988.00520350062017. Arch Neurol. 1988. PMID: 2847695

6

Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.

Direnfeld LK, Albert ML, Volicer L, Langlais PJ, Marquis J, Kaplan E. Direnfeld LK, et al. Among authors: albert ml. Arch Neurol. 1984 Sep;41(9):935-41. doi: 10.1001/archneur.1984.04050200041016. Arch Neurol. 1984. PMID: 6477229

7

Cross-Cultural Cognitive Examination performance in patients with Parkinson's disease and Alzheimer's disease.

Glosser G, Wolfe N, Kliner-Krenzel L, Albert ML. Glosser G, et al. Among authors: albert ml. J Nerv Ment Dis. 1994 Aug;182(8):432-6. doi: 10.1097/00005053-199408000-00002. J Nerv Ment Dis. 1994. PMID: 8040652

8

Cognitive changes in patients with multiple cerebral infarcts.

Babikian VL, Wolfe N, Linn R, Knoefel JE, Albert ML. Babikian VL, et al. Among authors: albert ml. Stroke. 1990 Jul;21(7):1013-8. doi: 10.1161/01.str.21.7.1013. Stroke. 1990. PMID: 2368101

9

Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer's type.

Volicer L, Direnfeld LK, Freedman M, Albert ML, Langlias PJ, Bird ED. Volicer L, et al. Among authors: albert ml. Arch Neurol. 1985 Feb;42(2):127-9. doi: 10.1001/archneur.1985.04060020037011. Arch Neurol. 1985. PMID: 2579625

10

CSF cyclic nucleotides and somatostatin in Parkinson's disease.

Volicer L, Beal MF, Direnfeld LK, Marquis JK, Albert ML. Volicer L, et al. Among authors: albert ml. Neurology. 1986 Jan;36(1):89-92. doi: 10.1212/wnl.36.1.89. Neurology. 1986. PMID: 2867490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters